A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis by Rosendahl, Jonas et al.
A Common Variant of PNPLA3 (p.I148M) Is Not
Associated with Alcoholic Chronic Pancreatitis
Jonas Rosendahl1*, Anke To¨njes2,3, Dorit Schleinitz4, Peter Kovacs4, Johannes Wiegand1, Claudia
Ruffert1, Moritz Jesinghaus1, Robert Schober1, Max Herms1, Robert Gru¨tzmann5, Hans-Ulrich Schulz6,
Felix Stickel7, Jens Werner8, Peter Bugert9, Matthias Blu¨her2,3, Michael Stumvoll2,3, Stephan Bo¨hm1,
Thomas Berg1, Henning Wittenburg1, Joachim Mo¨ssner1, Rene te Morsche10, Monique Derikx10, Volker
Keim1, Heiko Witt11, Joost P. H. Drenth10
1Division of Gastroenterology and Rheumatology, Department for Internal Medicine, Neurology and Dermatology, University of Leipzig, Leipzig, Germany, 2Division of
Endocrinology, Department for Internal Medicine, Neurology and Dermatology, University of Leipzig, Leipzig, Germany, 3 IFB Adiposity Diseases, University of Leipzig,
Leipzig, Germany, 4 Interdisciplinary Center for Clinical Research Leipzig, University of Leipzig, Leipzig, Germany, 5Department of General, Thoracic and Vascular Surgery,
University Hospital Carl Gustav Carus, Technische Universita¨t Dresden, Dresden, Germany, 6Department of Surgery, Otto-von-Guericke University Magdeburg,
Magdeburg, Germany, 7Department of Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland, 8Department of Surgery, University of Heidelberg,
Heidelberg, Germany, 9Medical Faculty Mannheim, Institute of Transfusion Medicine and Immunology, Heidelberg University, German Red Cross Blood Service of Baden-
Wu¨rttemberg-Hessen, Mannheim, Germany, 10Department of Gastroenterology and Hepatology, Nijmegen Medical Center, Radboud University, Nijmegen, The
Netherlands, 11Department of Pediatrics and Else Kro¨ner-Fresenius-Zentrum (EKFZ), Technical University Munich (TUM), Munich, Germany
Abstract
Background: Chronic pancreatitis (CP) is an inflammatory disease that in some patients leads to exocrine and endocrine
dysfunction. In industrialized countries the most common aetiology is chronic alcohol abuse. Descriptions of associated
genetic alterations in alcoholic CP are rare. However, a common PNPLA3 variant (p.I148M) is associated with the
development of alcoholic liver cirrhosis (ALC). Since, alcoholic CP and ALC share the same aetiology PNPLA3 variant
(p.I148M) possibly influences the development of alcoholic CP.
Methods: Using melting curve analysis we genotyped the variant in 1510 patients with pancreatitis or liver disease (961
German and Dutch alcoholic CP patients, 414 German patients with idiopathic or hereditary CP, and 135 patients with ALC).
In addition, we included in total 2781 healthy controls in the study.
Results: The previously published overrepresentation of GG-genotype was replicated in our cohort of ALC (p-value,0.0001,
OR 2.3, 95% CI 1.6–3.3). Distributions of genotype and allele frequencies of the p.I148M variant were comparable in patients
with alcoholic CP, idiopathic and hereditary CP and in healthy controls.
Conclusions: The absence of an association of PNPLA3 p.I148M with alcoholic CP seems not to point to a common pathway
in the development of alcoholic CP and alcoholic liver cirrhosis.
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Introduction
Chronic pancreatitis (CP) is a recurring or continuous
inflammatory disease that can lead to permanent impairment of
endocrine and exocrine function. In industrialized countries
continued alcohol abuse is the most common underlying cause.
Additionally, smoking increases the risk for CP [1]. Contrary to
other alcohol-induced disorders, such as liver cirrhosis, only 5% of
alcohol abusers develop CP [2]. In addition, familial clustering
suggests a contribution of genetic alterations to the pathogenesis of
alcoholic CP. In recent years several genetic associations have
been discovered for hereditary and idiopathic CP [3–7]. Although,
genetic case control studies in alcoholic CP have established robust
associations with variants of serine protease inhibitor, kazal type 1
(SPINK1) and chymotrypsinogen C (CTRC) search for other risk
variants have been less successful [8,9]. However, a Japanese study
performed a genome wide genetic analysis using microsatellite
markers in alcoholic CP and discovered several susceptibility
regions [10]. This suggests that whole genome information could
provide new insights to understanding the pathogenesis of
alcoholic CP and indicates that common variants might be of
importance.
A genome wide association study in patients with non-alcoholic
fatty liver disease revealed a link between PNPLA3 (OMIM
*609567) variants and liver fat content [11]. Subsequent
investigations analysed PNPLA3 variant p.I148M (rs738409) in
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alcoholic Mestizo individuals and demonstrated an overrepresen-
tation of the GG-genotype in those with alcoholic liver disease [12].
This genetic association was confirmed in different cohorts from
different ethnicities and the verdict is that rs738409 represents an
independent risk factor for ALC with odds-ratios (OR) in the
range of 2 that withstands multivariate analysis. In Caucasian
alcoholics, rs738409 was also associated with elevated amino-
transferase levels and in patients with chronic hepatitis C it
appears to influence progression to fibrosis and development of
steatosis [13–17].
Alcohol abuse is the predominant aetiology of CP and liver
cirrhosis in industrialized countries. Given the fact that PNPLA3
rs738409 is a risk factor for ALC it is evident to investigate its
potential influence on the pathogenesis of alcoholic CP. In
addition, both disease forms occur concomitantly in patients, albeit
rarely, which might suggest a potential common pathway for
disease development [18–21]. We therefore investigated PNPLA3
variant rs738409 in patients with alcoholic CP and screened
individuals with idiopathic and hereditary CP as well as a
confirmatory cohort of ALC patients.
Material and Methods
Patients
The study protocol was approved by the medical ethical review
committee of the University of Nijmegen (The Netherlands) and
Leipzig (Germany) and all patients gave written informed consent.
Diagnosis of CP was based on two or more of the following
findings. Presence of a typical history of recurrent pancreatitis or
recurrent abdominal pain typical for CP, pancreatic calcifications
and/or pancreatic ductal irregularities revealed by endoscopic
retrograde pancreaticography or by magnetic resonance imaging
of the pancreas and/or pathological sonographic findings.
Alcoholic CP was defined in patients who had consumed more
than 80 g/d alcohol for at least two years in men and more than
60 g/d for women. Hereditary CP was diagnosed when one first-
degree relative or two or more second-degree relatives suffered
from recurrent acute or CP without any apparent precipitating
factor. Idiopathic CP was diagnosed in the absence of a positive
family history or possible precipitating factors.
ALC was diagnosed according to results of liver biopsy (fibrosis
stage 4) or due to unequivocal clinical and laboratory findings in
men who consumed more than 80 g/d and in women who
consumed more than 60 g/d for at least 10 years. Such findings
were abnormal levels of aminotransferases, gamma glutamyl
transpeptidase, coagulation tests, serum albumin concentration,
platelet count, complications related to liver cirrhosis like
esophageal varices, ascites, hepatic encephalopathy and typical
liver morphology in sonography or computed tomography. Other
etiologies of liver cirrhosis were excluded by standard laboratory
tests.
Overall, we enrolled 755 German patients with alcoholic CP
(650 male, age range 23–82 years, median 48 years), 333 patients
with idiopathic CP and 81 patients with hereditary CP (202 male,
age range 1–75 years, median 20 years; known variants: PRSS1
variants: p.R122H n=16, p.N29I n= 5, p.A16V n= 1, p.D22G
n=1, p.L104P n= 1, p.R122C n= 1, p.C139F n= 1; SPINK1
variants: p.N34S homozygous n= 11, p.N34S heterozygous
n= 93, p.L14P n=1) and 128 patients with alcoholic liver
cirrhosis (97 male, age range 32–78 years, median 55.5 years).
In addition, we investigated 206 Dutch patients with alcoholic CP
(152 male, age range: 33–76 years, median 51 years) and 7 patients
with ALC (6 male, age range 49–61 years, median 56 years). We
analysed patients with alcoholic liver cirrhosis as one cohort. In
total, we screened 1950 blood donors from south-western and
eastern Germany (853 male, age range 18–81 years, median 49
years) and 831 healthy controls without CP from the Netherlands
(377 male, age range 18–96 years, median 50 years).
Genotyping
We extracted genomic DNA from peripheral blood leukocytes
according to a standard protocol (Qiagen, Hilden, Germany) and
performed polymerase chain reaction (PCR) using 0.75 U
AmpliTaq Gold polymerase (Applied Biosystems, Inc. Foster City,
CA, USA), 400 mM dNTPs, 1.5 mMMgCl2 and 0.4 mM F-Primer
as well as 0.1 mM R-primer in a total volume of 25 ml. Cycle
conditions were an initial denaturation for 12 minutes at 95uC
followed by 35 cycles of 20 seconds denaturation at 95uC,
40 seconds annealing at 60uC, 90 seconds primer extension at
72uC and a final extension for 2 minutes at 72uC in an automated
thermal cycler (Applied Biosystems, Carlsbad, USA). Primers were
synthesized according to the published nucleotide sequences
(PNPLA3: GenBank: NM_025225.2): F-Primer 59-CTTCTCTC-
TCCTTTgCTTTCAC-39, R-Primer 59-gCAggAgATgTgTgAg-
CAC-39.
We performed melting curve analysis in the LightCycler 480
instrument (Roche Diagnostics, Mannheim, Germany) using a
pair of fluorescent resonance energy transfer (FRET) probes.
FRET probes were designed complementary to the mutated
sequence. Probes were devised and synthesised by TIB Molbiol
(Berlin, Germany): Anchor probe 59-ACCACgCCTCTgAAg-
gAAggAgggATAAg-FL-39, Sensor probe 59-610-CCACTgTA-
gAACggCATgAAgC-39. Analytical melting included the following
steps: 95uC for 60 seconds, 35uC for 60 seconds and an increase to
70uC at a 0.14uC/s ramp rate. If melting curves distinguished
differently than expected from WT or mutated samples, we
performed DNA sequencing of the accordant sample to identify
the responsible variant.
Statistics
Power analysis was performed using QUANTO 1.1 in a case
control model [22]. We used the detected allele frequency of the
G-allele in German controls (23%) and performed analysis in an
additive model. The corresponding samples to controls ratio was
2.6, respectively (German patients, n = 755; German controls,
n = 1950).
We tested the significance of the differences between variant
frequencies in affected individuals and controls by two-tailed
Fisher’s Exact test and calculated p-values using GraphPad Prism
(v 4.03). For PNPLA3 variant p.I148M we utilised a dominant
model, defined as CC vs. GC+GG, for calculations and considered
p-values ,0.05 to be of statistical significance. In addition,
calculations were performed following a recessive model (CC+GC
vs. GG) and for allele frequencies.
Results
Power calculations
Considering a minor allele frequency of 23% that was obtained
in German controls we had a statistical power of at least 0.9
(a=0.05) to detect genetic effects with an OR $1.25. Of course
effects below a threshold of 1.25 (OR) might be missed, but we
reasoned that effects below this threshold should be of neglible
relevance for the pathogenesis of ACP.
PNPLA3 and pancreatitis
In our cohort of 755 German patients with alcoholic CP we
detected the rs738409 GG-genotype in 37/755 patients (4.9%) and
PNPLA3 in Alcoholic Chronic Pancreatitis
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found similar results in the Dutch group of patients with alcoholic
CP (8/206, 3.9%) (Table 1). Upon comparison with German and
Dutch controls our genotype data yielded similar distributions
(dominant model, p-value 0.07, 0.7). This was similar for the
overall cohort of alcoholic CP patients compared to the pooled
controls (dominant model, p-value 0.2). Allele frequencies of the G-
Allele were comparable in all groups (German ACP 323/1510,
21.4%; Dutch ACP 92/412, 22.3%; German controls 912/3900,
23.4%; Dutch controls 382/1662, 23%). However, when we
summarized all patients with alcoholic CP and compared
genotype and allele data with ALC patients we obtained a
significant attributed risk. We found a GG-Genotype in 45/961
(4.7%) of all patients with alcoholic CP, compared to 25/135
(18.5%) of ALC patients (dominant model, p-value ,0.0001, OR
2.3, 95% CI 1.6–3.3; 3.9-fold accumulation). If we focus on allele
frequencies we found that the G-allele was detectable in 415/1922
(21.6%) alleles in all alcoholic CP patients, while in ALC the G-
allele was present in 40.4% of all alleles (p-value,0.0001, OR 2.5,
95% CI 1.9–3.2).
In patients with idiopathic and hereditary CP allele frequencies
of rs738409 G-allele (193/828, 23.3%; p-value 0.4) were
comparable to those in controls, but the GG-genotype was more
frequent in patients (31/414, 7.5%) than in controls (97/1950,
5.0%). There was also no statistical significant difference between
groups with respect to genotype data (dominant model, p-value
1.0; recessive model, p-value 0.05).
PNPLA3 and alcoholic liver disease
In patients with ALC GG-genotype of rs738409 was more
frequent (3.7-fold) and present in 25/135 (18.5%) patients
compared to 97/1950 (5.0%) in German controls (dominant
model, p-value ,0.0001, OR 2.7, 95% CI 1.9–3.9) (Table 2).
When we pooled all controls GG-Genotype was 3.4-fold more
frequent, respectively (dominant model, 153/2781, 5.5%; p-value
,0.0001, OR 2.4, 95% CI 1.7–3.4). In patients with ALC G-Allele
accounted for 40.4% (109/270) of all alleles in comparison to
23.3% in controls (1294/5562; p-value ,0.0001, OR 2.2, 95% CI
1.7–2.9).
Discussion
The current study examines the influence of PNPLA3 variant
p.I148M in a large cohort of patients with alcoholic liver and
pancreas disease and controls.
We confirmed the association of PNPLA3 GG-genotype with
ALC in our cohort (p-value ,0.0001) and the overrepresentation
of GG-genotype compared to controls was 3.7-fold (OR 2.3, 95%
CI 1.6–3.3), respectively 3.4-fold (OR 2.4, 95% CI 1.7–3.4) for the
pooled control group, which is higher than found in recent studies
[13,14]. The difference might be due to a type 2 error as our ALC
patient group is relatively small precluding an accurate estimation
of the risk. Our analysis further supports the current knowledge
that PNPLA3 rs738409 represents a risk factor for ALC in different
ethnic groups with odds ratios around two.
Apart from putative genetic associations, little is known on the
functional consequences of PNPLA3 variant p.I148M. Recent data
demonstrated a reduced capacity of mutated PNPLA3 to
hydrolyse triglycerides with subsequent accumulation in the liver
[23]. One might speculate that also in patients with ACP
triglyceride haemostasis is disturbed with the result of CP due to
inflammatory processes in the pancreas. Due to the limited
knowledge of PNPLA3 function available so far one has to be
aware of the speculative character of the aforementioned theory.
Contrary to ALC, little is known about potential genetic
associations of alcoholic CP, despite knowledge of the role of
SPINK1 and CTRC variants in CP. Some patients with alcoholic
CP also suffer from ALC. Epidemiological data on simultaneous
presence of ALC and ACP are scarce and according to recent
findings more than one third of patients with alcoholic CP may
have concomitant ALC while around 20% of patients with ALC
suffer from CP [21]. It is worthy to point out that prevalence data
on the coexisting of alcoholic CP and ALC are inconsistent among
different studies [18–21]. The fact that precursor lesions of both
disease forms, steatosis and pancreatic fibrosis, are often found
concurrently, portends to potential concerted risk factors.
Our analysis of PNPLA3 variant p.I148M in German and Dutch
patients with alcoholic CP demonstrated similar data for genotype and
allele frequencies, when compared to pooled controls (p-value 0.2 and
Table 1. Genotype data of PNPLA3 variant rs738409 in German and Dutch patients with alcoholic CP and in German and Dutch
controls.
Variant Genotype Patients ACP Controls p-Value OR
German
p.I148M c.444C.G rs738409 CC 469/755 (62.1%) 1135/1950 (58.2%) n.s. -
GC 249/755 (33%) 718/1950 (36.8%)
GG 37/755 (4.9%) 97/1950 (5.0%)
Dutch
CC 122/206 (59.2%) 505/831 (60.8%) n.s. -
GC 76/206 (36.9%) 270/831 (32.5%)
GG 8/206 (3.9%) 56/831 (6.7%)
Pooled (German/Dutch)
CC 591/961 (61.5%) 1640/2781 (59%) n.s. -
GC 325/961 (33.8%) 988/2781 (35.5%)
GG 45/961 (4.7%) 153/2781 (5.5%)
Percentages are given in brackets. P-values were calculated for these groups in a dominant (CC vs. GC+GG) and recessive model (CC+GC vs. GG). Abbreviations:
ACP= alcoholic CP, n.s. = not significant.
doi:10.1371/journal.pone.0029433.t001
PNPLA3 in Alcoholic Chronic Pancreatitis
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29433
0.1). We also confirmed the association of PNPLA3 GG-genotype with
ALC when we analysed patients with alcoholic CP and compared
them to ALC (p-value,0.0001). As a consequence, the obtained data
of PNPLA3 variant rs738409 implicate that different pathways might
be implicated in the development of alcoholic CP and ALC.
We screened patients with idiopathic and hereditary CP to describe
the frequency of this variant in other forms of CP and found an
overrepresentation of GG-genotype compared to our control group.
However, calculation of genotype distribution in a dominant and
recessive model (p-value 1.0 and 0.05) and comparison of allele
frequencies (p-value 0.4) yielded no statistical significant different
results. This genetic result accords with the commonly accepted
pathophysiological model of idiopathic and hereditary CP.
Study limitations
Our study comes with limitations. Part of the control group used
for comparison are blood donors and as such this introduces
potential bias since ALC or APC may be prevalent among blood
donors. We surmise that the contribution of such an effect is rather
small. Blood donors are routinely screened for elevated liver
enzymes and patients with chronic alcohol abuse should not be
suitable to donate blood. Of note, in blood donors there might be
a selection of a distinct group (healthy persons that are willing to
donate blood), which may affect the obtained results. However,
according to the low incidence of both disease entities in the
general population we do not believe that will alter the results
substantially. We think that the risk for bias is limited because
genotype frequencies of rs738409 in our controls are similar to
that in other Caucasian controls reported so far [24,25].
Most of all, it has to be noted that we only investigated one
particular variant that was previously proven to be of importance
for alcohol related liver disease. Our results seem to indicate, that
the absence of an association of PNPLA3 variant p.I148M with
alcoholic CP does not point to a common pathway in the
development of alcoholic CP and ALC. However, we are aware
that our conclusions are limited by the fact that only one variant
with a modest risk for ALC whose pathogenic role is largely
unknown, was investigated in patients with ACP.
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